Tenon Medical, Inc.
TNON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.07 | 0.01 | 0.01 | 0.01 |
| FCF Yield | -38.14% | -32.43% | -32.72% | -120.05% |
| EV / EBITDA | -1.92 | 0.05 | 0.67 | 1.25 |
| Quality | ||||
| ROIC | -44.98% | -32.32% | -31.99% | -38.41% |
| Gross Margin | 65.90% | 43.44% | 44.49% | 45.84% |
| Cash Conversion Ratio | 1.15 | 0.80 | 0.69 | 0.90 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.49% | 21.06% | 46.10% | 68.01% |
| Free Cash Flow Growth | -54.32% | 3.10% | 9.38% | -11.97% |
| Safety | ||||
| Net Debt / EBITDA | 0.95 | 2.85 | 2.84 | 2.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 46.66 |
| Efficiency | ||||
| Inventory Turnover | 0.29 | 0.46 | 0.66 | 0.69 |
| Cash Conversion Cycle | 266.86 | 64.75 | 134.62 | 152.02 |